Relinking Diagnosed But Untreated HCV Patients Back Into Care.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 600
- Locations
- 1
- Primary Endpoint
- Retrospective data collection
Study Overview
Brief Summary
Reintroduction of patients into a HCV infection care pathway after a positive chronic hepatitis C diagnosis by previous testing in our hospital who were lost in follow-up.
Gaining insight in the possible reasons why patients are lost in follow-up after positive hepatitis C serology.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Other
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Positive HCV serology between 2012-2022 with positive or uknown HCV RNA in UZ Brussels database
- •≥18 years
Exclusion Criteria
- •Positive HCV serology with negative HCV RNA
- •Previously eradicated patients in UZ Brussel
Outcomes
Primary Outcomes
Retrospective data collection
Time Frame: before contacting the patient
Prevalence of diagnosed but untreated HCV patients through positive serology with positive or unknown HCV RNA in UZ Brussel between 2012 - 2022.
Prospective interventional study
Time Frame: from first contact of the patient till 12 weeks after end of treatment.
To recall DBU patients by phone, e-mail or letter, trying to optimize treated and cured patients after recall
Secondary Outcomes
- Reason lost in follow-up(from first contact of the patient till 12 weeks after end of treatment.)
